ORM-15341
CAS No. 1297537-33-7
ORM-15341( —— )
Catalog No. M11200 CAS No. 1297537-33-7
The active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 296 | In Stock |
|
| 100MG | 444 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameORM-15341
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor.
-
DescriptionThe active main metabolite of ODM-201, a potent wt/mutant androgen receptor (AR) inhibitor; inhibits wtAR/AR(F876L) with IC50s of 25/51 nM respectively; suppresses androgen-induced cell proliferation more efficaciously than enzalutamide or ARN-509.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor (AR)
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number1297537-33-7
-
Formula Weight396.8303
-
Molecular FormulaC19H17ClN6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 37 mg/mL
-
SMILESCC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=CC(=NN3)C(=O)C
-
Chemical Name1H-Pyrazole-3-carboxamide, 5-acetyl-N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moilanen AM, et al. Sci Rep. 2015 Jul 3;5:12007.
molnova catalog
related products
-
RD162
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.
-
ARN-509
ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate Y treatment.
-
BMS-641988 B
BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
Cart
sales@molnova.com